Learn More
Invitrogen™ Pozelimab Recombinant Monoclonal Antibody

Recombinant Monoclonal Antibody
Brand: Invitrogen™ MA559689
Description
For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °.
Pozelimab is an investigational fully human monoclonal antibody, invented using Regeneron's proprietary VelocImmune technology, which aims to block the complement signaling pathway by binding to complement factor C5. It also prevents the destruction of red blood cells (hemolysis) that causes paroxysmal nocturnal hemoglobinuria and other disease symptoms.
Specifications
| Pozelimab | |
| Recombinant Monoclonal | |
| Unconjugated | |
| REGN-3918 | |
| Protein A | |
| RUO | |
| Human | |
| Antibody | |
| IgG4SP |
| ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance | |
| 1 mg/mL | |
| 25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2 | |
| Human | |
| 100 μg | |
| Primary | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Lyophilized |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.